latest Post

Home / health / news The New York Times / Novartis C.E.O. Defends Company’s Decision to Withhold False Data From the F.D.A.

Novartis C.E.O. Defends Company’s Decision to Withhold False Data From the F.D.A.

August 07, 2019 health , news The New York Times Edit

By KATIE THOMAS from NYT Health https://ift.tt/2YPZ7N5

About librobucher

Recommended Posts × − +

0 comments:

Post a Comment

Subscribe to: Post Comments ( Atom )